$oscr 2023 Q4 10-K

Concept	2023 Q4	2023
Revenue	$1.432B	$5.863B
YoY Change	43.87%	47.92%
Cost Of Revenue		$4.642B
YoY Change		41.49%
Gross Profit		$1.221B
YoY Change		78.79%
Gross Profit Margin		20.82%
Selling, General & Admin	$159.9M	$630.4M
YoY Change	8.35%	0.47%
% of Gross Profit		51.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.694M	$30.69M
YoY Change	106.0%	100.61%
% of Gross Profit		2.51%
Operating Expenses	$1.577B	$6.098B
YoY Change	29.53%	33.93%
Operating Profit		-$235.6M
YoY Change		-60.06%
Interest Expense	-$6.217M	-$24.60M
YoY Change	1.34%	-208.75%
% of Operating Profit
Other Income/Expense, Net	$1.050M	-$7.082M
YoY Change	-21.58%	-393.25%
Pretax Income	-$150.6M	-$267.3M
YoY Change	-33.72%	-56.19%
Income Tax	-$806.0K	$3.294M
% Of Pretax Income
Net Earnings	-$150.0M	-$270.7M
YoY Change	-33.63%	-55.35%
Net Earnings / Revenue	-10.48%	-4.62%
Basic Earnings Per Share		-$1.22
Diluted Earnings Per Share	-$0.66	-$1.22
COMMON SHARES
Basic Shares Outstanding		221.7M shares
Diluted Shares Outstanding		221.7M shares

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.560B
YoY Change	-13.39%
Cash & Equivalents	$1.870B	$1.870B
Short-Term Investments	$689.8M
Other Short-Term Assets	$6.564M
YoY Change	1.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$51.93M	$51.93M
YoY Change	-98.74%	4.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$61.93M	$61.93M
YoY Change	3.41%	-51.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.055B	$1.055B
YoY Change	-34.88%	-34.88%
Other Assets	$29.87M	$29.87M
YoY Change	-68.48%	8.69%
Total Long-Term Assets	$3.550B	$3.550B
YoY Change	776.33%	-20.71%
TOTAL ASSETS
Total Short-Term Assets	$51.93M	$51.93M
Total Long-Term Assets	$3.550B	$3.550B
Total Assets	$3.601B	$3.601B
YoY Change	-20.44%	-20.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$273.4M	$273.4M
YoY Change	-4.09%	-4.09%
Accrued Expenses		$80.98M
YoY Change		-4.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$273.4M	$273.4M
YoY Change	-91.62%	-26.12%
LONG-TERM LIABILITIES
Long-Term Debt	$298.8M	$298.8M
YoY Change	0.26%	0.26%
Other Long-Term Liabilities	$67.57M	$67.57M
YoY Change	-6.51%	64256.19%
Total Long-Term Liabilities	$366.4M	$366.4M
YoY Change	-1.06%	22.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$273.4M	$273.4M
Total Long-Term Liabilities	$366.4M	$366.4M
Total Liabilities	$2.798B	$2.798B
YoY Change	-23.02%	-23.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.877B
YoY Change	10.39%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.923M
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$804.0M	$804.0M
YoY Change
Total Liabilities & Shareholders Equity	$3.601B	$3.601B
YoY Change	-20.44%	-20.44%

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$150.0M	-$270.7M
YoY Change	-33.63%	-55.35%
Depreciation, Depletion And Amortization	$7.694M	$30.69M
YoY Change	106.0%	100.61%
Cash From Operating Activities	$296.8M	-$272.2M
YoY Change	96.07%	-171.56%
INVESTING ACTIVITIES
Capital Expenditures	$6.077M	$25.58M
YoY Change	-14.77%	-11.84%
Acquisitions
YoY Change
Other Investing Activities	$178.6M	$602.8M
YoY Change	-125.53%	-405.19%
Cash From Investing Activities	$172.5M	$577.2M
YoY Change	-124.41%	-354.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.056M	$3.956M
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	1.046M	6.446M
YoY Change	98.48%	-97.86%
NET CHANGE
Cash From Operating Activities	296.8M	-272.2M
Cash From Investing Activities	172.5M	577.2M
Cash From Financing Activities	1.046M	6.446M
Net Change In Cash	470.4M	311.5M
YoY Change	-184.79%	-31.54%
FREE CASH FLOW
Cash From Operating Activities	$296.8M	-$272.2M
Capital Expenditures	$6.077M	$25.58M
Free Cash Flow	$290.8M	-$297.7M
YoY Change	101.55%	-184.74%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2876715000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1309000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	803967000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	2150000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	806117000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3601480000	usd
CY2023	oscr	Premiums Earned Before Premiums Ceded PremiumsEarnedBeforePremiumsCeded	5696978000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5394000	usd
CY2023Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	57111000	usd
CY2022	us-gaap	Revenues Revenues	3963638000	usd
CY2023	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	4642024000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	3280798000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1623995000	usd
CY2023	oscr	Other Insurance Expense Net OtherInsuranceExpenseNet	824457000	usd
CY2022	oscr	Other Insurance Expense Net OtherInsuranceExpenseNet	706439000	usd
CY2021	oscr	Other Insurance Expense Net OtherInsuranceExpenseNet	410363000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	309783000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	265078000	usd
CY2021	oscr	Federal And State Assessment Expense FederalAndStateAssessmentExpense	139085000	usd
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001568651
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.33
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40154
CY2023	dei	Entity Registrant Name EntityRegistrantName	Oscar Health, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-1315570
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	75 Varick Street, 5th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York,
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10013
CY2023	dei	City Area Code CityAreaCode	(646)
CY2023	dei	Local Phone Number LocalPhoneNumber	403-3677
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.00001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	OSCR
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1500000000	usd
CY2023	dei	Auditor Firm AuditorFirmId	238
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1870315000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1558595000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	689833000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1397287000	usd
CY2023Q4	oscr	Premiums And Other Receivables Allowance For Credit Loss PremiumsAndOtherReceivablesAllowanceForCreditLoss	31600000	usd
CY2022Q4	oscr	Premiums And Other Receivables Allowance For Credit Loss PremiumsAndOtherReceivablesAllowanceForCreditLoss	2988000	usd
CY2023Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	201269000	usd
CY2022Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	216475000	usd
CY2023Q4	oscr	Risk Adjustment Transfer Receivables Current RiskAdjustmentTransferReceivablesCurrent	51925000	usd
CY2022Q4	oscr	Risk Adjustment Transfer Receivables Current RiskAdjustmentTransferReceivablesCurrent	49861000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	241194000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	892887000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6564000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6450000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3061100000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4121555000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61930000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59888000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	365309000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	222919000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	29870000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	27483000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	83271000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94756000	usd
CY2023Q4	us-gaap	Assets Assets	3601480000	usd
CY2022Q4	us-gaap	Assets Assets	4526601000	usd
CY2023Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	965986000	usd
CY2022Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	937727000	usd
CY2023Q4	oscr	Risk Adjustment Transfer Payable Current RiskAdjustmentTransferPayableCurrent	1056941000	usd
CY2022Q4	oscr	Risk Adjustment Transfer Payable Current RiskAdjustmentTransferPayableCurrent	1517493000	usd
CY2023Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	5776000	usd
CY2022Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	4214000	usd
CY2023Q4	us-gaap	Unearned Premiums UnearnedPremiums	65918000	usd
CY2022Q4	us-gaap	Unearned Premiums UnearnedPremiums	78998000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	273367000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	297841000	usd
CY2023Q4	us-gaap	Reinsurance Payable ReinsurancePayable	61024000	usd
CY2022Q4	us-gaap	Reinsurance Payable ReinsurancePayable	427649000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2429012000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3263922000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	298777000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	297999000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	67574000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	72280000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2795363000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3634201000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	314600	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	314600	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2923000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2923000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3682294000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3509007000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2605987000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9715000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	890384000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2016000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892400000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4526601000	usd
CY2022	oscr	Premiums Earned Before Premiums Ceded PremiumsEarnedBeforePremiumsCeded	5334520000	usd
CY2021	oscr	Premiums Earned Before Premiums Ceded PremiumsEarnedBeforePremiumsCeded	2712988000	usd
CY2023	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	10909000	usd
CY2022	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	1463403000	usd
CY2021	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	881968000	usd
CY2023	us-gaap	Premiums Earned Net PremiumsEarnedNet	5686069000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	3871117000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	1831020000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15442000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61047000	usd
CY2023	oscr	Net Investment Income Gain Loss On Investments And Other Income NetInvestmentIncomeGainLossOnInvestmentsAndOtherIncome	161358000	usd
CY2022	oscr	Net Investment Income Gain Loss On Investments And Other Income NetInvestmentIncomeGainLossOnInvestmentsAndOtherIncome	31474000	usd
CY2021	oscr	Net Investment Income Gain Loss On Investments And Other Income NetInvestmentIncomeGainLossOnInvestmentsAndOtherIncome	2301000	usd
CY2023	us-gaap	Revenues Revenues	5862869000	usd
CY2021	us-gaap	Revenues Revenues	1838715000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	339716000	usd
CY2023	oscr	Federal And State Assessment Expense FederalAndStateAssessmentExpense	290725000	usd
CY2022	oscr	Federal And State Assessment Expense FederalAndStateAssessmentExpense	281518000	usd
CY2023	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	1562000	usd
CY2022	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	-25033000	usd
CY2021	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	-55325000	usd
CY2023	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	6098484000	usd
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4553505000	usd
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2383196000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-235615000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-589867000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-544481000	usd
CY2023	us-gaap	Interest Expense InterestExpense	24603000	usd
CY2022	us-gaap	Interest Expense InterestExpense	22623000	usd
CY2021	us-gaap	Interest Expense InterestExpense	4720000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7082000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2415000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1201000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20178000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-267300000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-610075000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-570580000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3294000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-523000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	846000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-270594000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-609552000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-571426000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	134000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3277000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1180000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-270728000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-606275000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-572606000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.85
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.85
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.20
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.20
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	221655493	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	221655493	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	212474615	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	212474615	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	178967056	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	178967056	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-270594000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-609552000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-571426000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	11024000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6044000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-4550000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-259570000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-615596000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-575976000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	134000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3277000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1180000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-259704000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-612319000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-577156000	usd
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	400904302	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1744911000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1295893000	usd
CY2021	oscr	Temporary Equity Conversion To Permanent Equity Shares TemporaryEquityConversionToPermanentEquityShares	400904302	shares
CY2021	oscr	Temporary Equity Conversion To Permanent Equity Value TemporaryEquityConversionToPermanentEquityValue	1744911000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1744910000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1338875000	usd
CY2021	oscr	Stock Issued During Period Value Warrants And Call Options Exercised StockIssuedDuringPeriodValueWarrantsAndCallOptionsExercised	37071000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	50009000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86296000	usd
CY2021	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	7230000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-4550000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-571426000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1392522000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1299000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	112329000	usd
CY2022	oscr	Adjustments To Additional Paid In Capital Joint Venture Contribution AdjustmentsToAdditionalPaidInCapitalJointVentureContribution	1846000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6044000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-609552000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892400000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3956000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	166841000	usd
CY2023	oscr	Adjustments To Additional Paid In Capital Joint Venture Contribution AdjustmentsToAdditionalPaidInCapitalJointVentureContribution	2490000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	11024000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-270594000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	806117000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-609552000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-571426000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	58000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-165000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-101000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-70000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1274000	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	209000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	12856000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30694000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15283000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14605000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	778000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	713000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	329000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	159683000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	112329000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	86296000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	29374000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2480000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-8031000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20178000	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	28612000	usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	2988000	usd
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	0	usd
CY2023	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	13405000	usd
CY2022	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	81049000	usd
CY2021	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	66953000	usd
CY2023	oscr	Increase Decrease In Risk Adjustment Transfer Receivables IncreaseDecreaseInRiskAdjustmentTransferReceivables	2063000	usd
CY2022	oscr	Increase Decrease In Risk Adjustment Transfer Receivables IncreaseDecreaseInRiskAdjustmentTransferReceivables	9202000	usd
CY2021	oscr	Increase Decrease In Risk Adjustment Transfer Receivables IncreaseDecreaseInRiskAdjustmentTransferReceivables	9502000	usd
CY2023	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-651693000	usd
CY2022	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	460897000	usd
CY2021	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-147403000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-11307000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	243000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11299000	usd
CY2023	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	28258000	usd
CY2022	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	424146000	usd
CY2021	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	201667000	usd
CY2023	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-13080000	usd
CY2022	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	3953000	usd
CY2021	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	3140000	usd
CY2023	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	1562000	usd
CY2022	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-25033000	usd
CY2021	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-55325000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-29180000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	57811000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	98619000	usd
CY2023	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	-366626000	usd
CY2022	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	222418000	usd
CY2021	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	-138082000	usd
CY2023	oscr	Increase Decrease In Risk Adjustment Transfer Payable IncreaseDecreaseInRiskAdjustmentTransferPayable	-460552000	usd
CY2022	oscr	Increase Decrease In Risk Adjustment Transfer Payable IncreaseDecreaseInRiskAdjustmentTransferPayable	723095000	usd
CY2021	oscr	Increase Decrease In Risk Adjustment Transfer Payable IncreaseDecreaseInRiskAdjustmentTransferPayable	78028000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-272159000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	380349000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-181745000	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	836982000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1192706000	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	1810076000	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	31857000	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	360616000	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	624077000	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1410166000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	633467000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	430694000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	25577000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	29012000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	25885000	usd
CY2023	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	2277000	usd
CY2022	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	-1116000	usd
CY2021	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	-6675000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	577187000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226519000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-774515000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	305000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7035000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	2490000	usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	1846000	usd
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	153173000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	12994000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1348321000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9447000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9191000	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Reclassification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has made certain reclassifications to prior period amounts to conform to the current period presentation within the accompanying Consolidated Financial Statements and notes to the Consolidated Financial Statements.</span></div>
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2021	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7230000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3956000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1299000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	49584000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6446000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	301110000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1238712000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	311474000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	454940000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	282452000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1580497000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1125557000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	843105000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1891971000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1580497000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1125557000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1870315000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1558595000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1103995000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	21656000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	21902000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	21562000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1891971000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1580497000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1125557000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	23156000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	10079000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4256000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2414000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1893000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	697000	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1744911000	usd
CY2023	oscr	Net Exercise Of Preferred Stock Warrants To Common Stock NetExerciseOfPreferredStockWarrantsToCommonStock	0	usd
CY2022	oscr	Net Exercise Of Preferred Stock Warrants To Common Stock NetExerciseOfPreferredStockWarrantsToCommonStock	0	usd
CY2021	oscr	Net Exercise Of Preferred Stock Warrants To Common Stock NetExerciseOfPreferredStockWarrantsToCommonStock	28248000	usd
CY2023	oscr	Fair Value Adjustment Preferred Stock Warrant Liability FairValueAdjustmentPreferredStockWarrantLiability	0	usd
CY2022	oscr	Fair Value Adjustment Preferred Stock Warrant Liability FairValueAdjustmentPreferredStockWarrantLiability	0	usd
CY2021	oscr	Fair Value Adjustment Preferred Stock Warrant Liability FairValueAdjustmentPreferredStockWarrantLiability	13243000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Direct Premiums Earned DirectPremiumsEarned	6418872000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Significant estimates inherent in the preparation of the accompanying audited Consolidated Financial Statements include healthcare costs incurred but not yet reported (“IBNR”), and risk adjustment. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ materially from these estimates.</span></div>
CY2023	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Change in Accounting Principle</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2022, the Company elected to include anticipated net investment income in its determination of premium deficiency reserves. The accounting policy election to include net investment income is preferable because it best reflects the ultimate profitability of insurance contracts using all cash flows, inclusive of related investment income, and provides improved comparability with industry peers. This change is considered a change in accounting principle that requires retrospective application to all financial statement periods presented. However, because net investment income has historically been immaterial to the financial statements and to the premium deficiency reserve calculation, the effect of this change in accounting principle is immaterial to prior and current period balances. As a result, this change in accounting principle is being applied prospectively as of December 31, 2022.</span></div>
CY2022Q4	oscr	Premiums And Other Receivables Allowance For Credit Loss PremiumsAndOtherReceivablesAllowanceForCreditLoss	2988000	usd
CY2021Q4	oscr	Premiums And Other Receivables Allowance For Credit Loss PremiumsAndOtherReceivablesAllowanceForCreditLoss	0	usd
CY2023	oscr	Premiums And Other Receivables Allowance For Credit Loss Period Increase Decrease PremiumsAndOtherReceivablesAllowanceForCreditLossPeriodIncreaseDecrease	28612000	usd
CY2022	oscr	Premiums And Other Receivables Allowance For Credit Loss Period Increase Decrease PremiumsAndOtherReceivablesAllowanceForCreditLossPeriodIncreaseDecrease	2988000	usd
CY2023Q4	oscr	Premiums And Other Receivables Allowance For Credit Loss PremiumsAndOtherReceivablesAllowanceForCreditLoss	31600000	usd
CY2022Q4	oscr	Premiums And Other Receivables Allowance For Credit Loss PremiumsAndOtherReceivablesAllowanceForCreditLoss	2988000	usd
CY2023Q4	us-gaap	Liability For Title Claims And Claims Adjustment Expense LiabilityForTitleClaimsAndClaimsAdjustmentExpense	241100000	usd
CY2022Q4	us-gaap	Liability For Title Claims And Claims Adjustment Expense LiabilityForTitleClaimsAndClaimsAdjustmentExpense	251100000	usd
CY2022	us-gaap	Direct Premiums Earned DirectPremiumsEarned	6704330000	usd
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	3420328000	usd
CY2023	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	228786000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	138109000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	16298000	usd
CY2023	oscr	Direct And Assumed Premiums Earned DirectAndAssumedPremiumsEarned	6647658000	usd
CY2022	oscr	Direct And Assumed Premiums Earned DirectAndAssumedPremiumsEarned	6842439000	usd
CY2021	oscr	Direct And Assumed Premiums Earned DirectAndAssumedPremiumsEarned	3436626000	usd
CY2023	oscr	Premiums Earned Risk Adjustment PremiumsEarnedRiskAdjustment	950680000	usd
CY2022	oscr	Premiums Earned Risk Adjustment PremiumsEarnedRiskAdjustment	1507919000	usd
CY2021	oscr	Premiums Earned Risk Adjustment PremiumsEarnedRiskAdjustment	723638000	usd
CY2023	oscr	Premiums Earned Before Premiums Ceded PremiumsEarnedBeforePremiumsCeded	5696978000	usd
CY2022	oscr	Premiums Earned Before Premiums Ceded PremiumsEarnedBeforePremiumsCeded	5334520000	usd
CY2021	oscr	Premiums Earned Before Premiums Ceded PremiumsEarnedBeforePremiumsCeded	2712988000	usd
CY2023	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	10909000	usd
CY2022	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	1463403000	usd
CY2021	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	881968000	usd
CY2023	us-gaap	Premiums Earned Net PremiumsEarnedNet	5686069000	usd
CY2022	us-gaap	Premiums Earned Net PremiumsEarnedNet	3871117000	usd
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	1831020000	usd
CY2023Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	200000	usd
CY2022Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	33700000	usd
CY2023	oscr	Quota Share Reinsurance Program Percentage Of Premiums Ceded QuotaShareReinsuranceProgramPercentageOfPremiumsCeded	0.45
CY2022	oscr	Quota Share Reinsurance Program Percentage Of Premiums Ceded QuotaShareReinsuranceProgramPercentageOfPremiumsCeded	0.18
CY2021	oscr	Quota Share Reinsurance Program Percentage Of Premiums Ceded QuotaShareReinsuranceProgramPercentageOfPremiumsCeded	0
CY2022	oscr	Quota Share Reinsurance Program Percentage Of Premiums Covered QuotaShareReinsuranceProgramPercentageOfPremiumsCovered	0.29
CY2021	oscr	Quota Share Reinsurance Program Percentage Of Premiums Covered QuotaShareReinsuranceProgramPercentageOfPremiumsCovered	0.34
CY2023Q4	oscr	Reinsurance Deposit Liability ReinsuranceDepositLiability	7000000	usd
CY2022Q4	oscr	Reinsurance Deposit Liability ReinsuranceDepositLiability	1800000	usd
CY2023	oscr	Ceded Premiums Earned Gross CededPremiumsEarnedGross	-56000	usd
CY2022	oscr	Ceded Premiums Earned Gross CededPremiumsEarnedGross	1524157000	usd
CY2021	oscr	Ceded Premiums Earned Gross CededPremiumsEarnedGross	921953000	usd
CY2023	oscr	Ceded Premiums Experience Refund CededPremiumsExperienceRefund	-10965000	usd
CY2022	oscr	Ceded Premiums Experience Refund CededPremiumsExperienceRefund	60754000	usd
CY2021	oscr	Ceded Premiums Experience Refund CededPremiumsExperienceRefund	39985000	usd
CY2023	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	10909000	usd
CY2022	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	1463403000	usd
CY2021	oscr	Ceded Premiums Earned Including Prior Period Adjustments CededPremiumsEarnedIncludingPriorPeriodAdjustments	881968000	usd
CY2023	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	228786000	usd
CY2022	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	138109000	usd
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	16298000	usd
CY2023	oscr	Ceded Premiums Earned Net Of Assumed Premiums Earned CededPremiumsEarnedNetOfAssumedPremiumsEarned	-217877000	usd
CY2022	oscr	Ceded Premiums Earned Net Of Assumed Premiums Earned CededPremiumsEarnedNetOfAssumedPremiumsEarned	1325294000	usd
CY2021	oscr	Ceded Premiums Earned Net Of Assumed Premiums Earned CededPremiumsEarnedNetOfAssumedPremiumsEarned	865670000	usd
CY2023	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	4459702000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	4428000000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	2403108000	usd
CY2023	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	44736000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	1290349000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	800769000	usd
CY2023	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	227058000	usd
CY2022	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	143147000	usd
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	21656000	usd
CY2022Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	5581000	usd
CY2023	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	4642024000	usd
CY2022	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	3280798000	usd
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1623995000	usd
CY2023	oscr	Other Insurance Expense Gross OtherInsuranceExpenseGross	823455000	usd
CY2022	oscr	Other Insurance Expense Gross OtherInsuranceExpenseGross	868385000	usd
CY2021	oscr	Other Insurance Expense Gross OtherInsuranceExpenseGross	492609000	usd
CY2023	oscr	Ceded Commission Income CededCommissionIncome	-1002000	usd
CY2022	oscr	Ceded Commission Income CededCommissionIncome	161946000	usd
CY2021	oscr	Ceded Commission Income CededCommissionIncome	82246000	usd
CY2023	oscr	Other Insurance Expense Net OtherInsuranceExpenseNet	824457000	usd
CY2022	oscr	Other Insurance Expense Net OtherInsuranceExpenseNet	706439000	usd
CY2021	oscr	Other Insurance Expense Net OtherInsuranceExpenseNet	410363000	usd
CY2023Q4	oscr	Reinsurance Recoverable For Paid And Unpaid Ceded Claims And Claims Adjustments ReinsuranceRecoverableForPaidAndUnpaidCededClaimsAndClaimsAdjustments	225705000	usd
CY2022Q4	oscr	Reinsurance Recoverable For Paid And Unpaid Ceded Claims And Claims Adjustments ReinsuranceRecoverableForPaidAndUnpaidCededClaimsAndClaimsAdjustments	776266000	usd
CY2023Q4	oscr	Reinsurance Recoverable Ceded Commissions ReinsuranceRecoverableCededCommissions	6185000	usd
CY2022Q4	oscr	Reinsurance Recoverable Ceded Commissions ReinsuranceRecoverableCededCommissions	42805000	usd
CY2023Q4	oscr	Reinsurance Recoverable Experience Refunds ReinsuranceRecoverableExperienceRefunds	9304000	usd
CY2022Q4	oscr	Reinsurance Recoverable Experience Refunds ReinsuranceRecoverableExperienceRefunds	73816000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	241194000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	892887000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	21656000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	21902000	usd
CY2023Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	8214000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	29870000	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	27483000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1053859000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2543000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1260000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1055142000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1629814000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	155000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9763000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1620206000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	133	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	559336000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1161000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	308	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	724614000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1775000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	23	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	30096000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	99000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	291	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	516085000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	7988000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	690694000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	689833000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	363165000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	365309000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1053859000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1055142000	usd
CY2023	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	156265000	usd
CY2022	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	28632000	usd
CY2021	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	3237000	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	818000	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1038000	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	5100000	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	842000	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	155447000	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	27594000	usd

CY2023Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-2876715000

usd

CY2023Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

1309000

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

803967000

usd

CY2023Q4

us-gaap

Minority Interest

MinorityInterest

2150000

usd

CY2023Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

806117000

usd

CY2023Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

3601480000

usd

CY2023

oscr

Premiums Earned Before Premiums Ceded

PremiumsEarnedBeforePremiumsCeded

5696978000

usd

CY2021

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

5394000

usd

CY2023Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

57111000

usd

CY2022

us-gaap

Revenues

3963638000

usd

CY2023

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

4642024000

usd

CY2022

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

3280798000

usd

CY2021

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

1623995000

usd

CY2023

oscr

Other Insurance Expense Net

OtherInsuranceExpenseNet

824457000

usd

CY2022

oscr

Other Insurance Expense Net

OtherInsuranceExpenseNet

706439000

usd

CY2021

oscr

Other Insurance Expense Net

OtherInsuranceExpenseNet

410363000

usd

CY2022

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

309783000

usd

CY2021

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

265078000

usd

CY2021

oscr

Federal And State Assessment Expense

FederalAndStateAssessmentExpense

139085000

usd

CY2023

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2023

CY2023

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2023

dei

Amendment Flag

AmendmentFlag

false

CY2023

dei

Entity Central Index Key

EntityCentralIndexKey

0001568651

CY2021Q1

us-gaap

Stockholders Equity Note Stock Split Conversion Ratio1

StockholdersEquityNoteStockSplitConversionRatio1

0.33

CY2022Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent

CY2023Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent

CY2022Q4

us-gaap

Operating Lease Liability Current Statement Of Financial Position Extensible List

OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent

CY2023Q4

us-gaap

Operating Lease Liability Current Statement Of Financial Position Extensible List

OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent

CY2023Q4

us-gaap

Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List

OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent

CY2022Q4

us-gaap

Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List

OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent

CY2023

dei

Document Annual Report

DocumentAnnualReport

true

CY2023

dei

Document Period End Date

DocumentPeriodEndDate

2023-12-31

CY2023

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2023

dei

Document Transition Report

DocumentTransitionReport

false

CY2023

dei

Entity File Number

EntityFileNumber

001-40154

CY2023

dei

Entity Registrant Name

EntityRegistrantName

Oscar Health, Inc.

CY2023

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2023

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

46-1315570

CY2023

dei

Entity Address Address Line1

EntityAddressAddressLine1

75 Varick Street, 5th Floor

CY2023

dei

Entity Address City Or Town

EntityAddressCityOrTown

New York,

CY2023

dei

Entity Address State Or Province

EntityAddressStateOrProvince

NY

CY2023

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

10013

CY2023

dei

City Area Code

CityAreaCode

(646)

CY2023

dei

Local Phone Number

LocalPhoneNumber

403-3677

CY2023

dei

Security12b Title

Security12bTitle

Class A Common Stock, $0.00001 par value per share

CY2023

dei

Trading Symbol

TradingSymbol

OSCR

CY2023

dei

Security Exchange Name

SecurityExchangeName

NYSE

CY2023

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

No

CY2023

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2023

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2023

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2023

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2023

dei

Entity Small Business

EntitySmallBusiness

false

CY2023

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2023

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

true

CY2023

dei

Document Fin Stmt Error Correction Flag

DocumentFinStmtErrorCorrectionFlag

false

CY2023

dei

Entity Shell Company

EntityShellCompany

false

CY2023Q2

dei

Entity Public Float

EntityPublicFloat

1500000000

usd

CY2023

dei

Auditor Firm

AuditorFirmId

238

CY2023

dei

Auditor Name

AuditorName

PricewaterhouseCoopers LLP

CY2023

dei

Auditor Location

AuditorLocation

Philadelphia, Pennsylvania

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

1870315000

usd

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

1558595000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Securities Current

AvailableForSaleSecuritiesDebtSecuritiesCurrent

689833000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Securities Current

AvailableForSaleSecuritiesDebtSecuritiesCurrent

1397287000

usd

CY2023Q4

oscr

Premiums And Other Receivables Allowance For Credit Loss

PremiumsAndOtherReceivablesAllowanceForCreditLoss

31600000

usd

CY2022Q4

oscr

Premiums And Other Receivables Allowance For Credit Loss

PremiumsAndOtherReceivablesAllowanceForCreditLoss

2988000

usd

CY2023Q4

us-gaap

Premiums And Other Receivables Net

PremiumsAndOtherReceivablesNet

201269000

usd

CY2022Q4

us-gaap

Premiums And Other Receivables Net

PremiumsAndOtherReceivablesNet

216475000

usd

CY2023Q4

oscr

Risk Adjustment Transfer Receivables Current

RiskAdjustmentTransferReceivablesCurrent

51925000

usd

CY2022Q4

oscr

Risk Adjustment Transfer Receivables Current

RiskAdjustmentTransferReceivablesCurrent

49861000

usd

CY2023Q4

us-gaap

Reinsurance Recoverables On Paid And Unpaid Losses

ReinsuranceRecoverablesOnPaidAndUnpaidLosses

241194000

usd

CY2022Q4

us-gaap

Reinsurance Recoverables On Paid And Unpaid Losses

ReinsuranceRecoverablesOnPaidAndUnpaidLosses

892887000

usd

CY2023Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

6564000

usd

CY2022Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

6450000

usd

CY2023Q4

us-gaap

Assets Current

AssetsCurrent

3061100000

usd

CY2022Q4

us-gaap

Assets Current

AssetsCurrent

4121555000

usd

CY2023Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

61930000

usd

CY2022Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

59888000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Securities Noncurrent

AvailableForSaleSecuritiesDebtSecuritiesNoncurrent

365309000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Securities Noncurrent

AvailableForSaleSecuritiesDebtSecuritiesNoncurrent

222919000

usd

CY2023Q4

us-gaap

Restricted Cash And Investments Noncurrent

RestrictedCashAndInvestmentsNoncurrent

29870000

usd

CY2022Q4

us-gaap

Restricted Cash And Investments Noncurrent

RestrictedCashAndInvestmentsNoncurrent

27483000

usd

CY2023Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

83271000

usd

CY2022Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

94756000

usd

CY2023Q4

us-gaap

Assets

3601480000

usd

CY2022Q4

us-gaap

Assets

4526601000

usd

CY2023Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

965986000

usd

CY2022Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

937727000

usd

CY2023Q4

oscr

Risk Adjustment Transfer Payable Current

RiskAdjustmentTransferPayableCurrent

1056941000

usd

CY2022Q4

oscr

Risk Adjustment Transfer Payable Current

RiskAdjustmentTransferPayableCurrent

1517493000

usd

CY2023Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

5776000

usd

CY2022Q4

us-gaap

Liability For Future Policy Benefits

LiabilityForFuturePolicyBenefits

4214000

usd

CY2023Q4

us-gaap

Unearned Premiums

UnearnedPremiums

65918000

usd

CY2022Q4

us-gaap

Unearned Premiums

UnearnedPremiums

78998000

usd

CY2023Q4

us-gaap

Accounts Payable And Accrued Liabilities Current

AccountsPayableAndAccruedLiabilitiesCurrent

273367000

usd

CY2022Q4

us-gaap

Accounts Payable And Accrued Liabilities Current

AccountsPayableAndAccruedLiabilitiesCurrent

297841000

usd

CY2023Q4

us-gaap

Reinsurance Payable

ReinsurancePayable

61024000

usd

CY2022Q4

us-gaap

Reinsurance Payable

ReinsurancePayable

427649000

usd

CY2023Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

2429012000

usd

CY2022Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

3263922000

usd

CY2023Q4

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

298777000

usd

CY2022Q4

us-gaap

Long Term Debt Noncurrent

LongTermDebtNoncurrent

297999000

usd

CY2023Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

67574000

usd

CY2022Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

72280000

usd

CY2023Q4

us-gaap

Liabilities

2795363000

usd

CY2022Q4

us-gaap

Liabilities

3634201000

usd

CY2023Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2022Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023Q4

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

314600

shares

CY2022Q4

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

314600

shares

CY2023Q4

us-gaap

Treasury Stock Common Value

TreasuryStockCommonValue

2923000

usd

CY2022Q4

us-gaap

Treasury Stock Common Value

TreasuryStockCommonValue

2923000

usd

CY2023Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

3682294000

usd

CY2022Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

3509007000

usd

CY2022Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-2605987000

usd

CY2022Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-9715000

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

890384000

usd

CY2022Q4

us-gaap

Minority Interest

MinorityInterest

2016000

usd

CY2022Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

892400000

usd

CY2022Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

4526601000

usd

CY2022

oscr

Premiums Earned Before Premiums Ceded

PremiumsEarnedBeforePremiumsCeded

5334520000

usd

CY2021

oscr

Premiums Earned Before Premiums Ceded

PremiumsEarnedBeforePremiumsCeded

2712988000

usd

CY2023

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

10909000

usd

CY2022

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

1463403000

usd

CY2021

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

881968000

usd

CY2023

us-gaap

Premiums Earned Net

PremiumsEarnedNet

5686069000

usd

CY2022

us-gaap

Premiums Earned Net

PremiumsEarnedNet

3871117000

usd

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

1831020000

usd

CY2023

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

15442000

usd

CY2022

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

61047000

usd

CY2023

oscr

Net Investment Income Gain Loss On Investments And Other Income

NetInvestmentIncomeGainLossOnInvestmentsAndOtherIncome

161358000

usd

CY2022

oscr

Net Investment Income Gain Loss On Investments And Other Income

NetInvestmentIncomeGainLossOnInvestmentsAndOtherIncome

31474000

usd

CY2021

oscr

Net Investment Income Gain Loss On Investments And Other Income

NetInvestmentIncomeGainLossOnInvestmentsAndOtherIncome

2301000

usd

CY2023

us-gaap

Revenues

5862869000

usd

CY2021

us-gaap

Revenues

1838715000

usd

CY2023

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

339716000

usd

CY2023

oscr

Federal And State Assessment Expense

FederalAndStateAssessmentExpense

290725000

usd

CY2022

oscr

Federal And State Assessment Expense

FederalAndStateAssessmentExpense

281518000

usd

CY2023

us-gaap

Liability For Future Policy Benefits Period Expense

LiabilityForFuturePolicyBenefitsPeriodExpense

1562000

usd

CY2022

us-gaap

Liability For Future Policy Benefits Period Expense

LiabilityForFuturePolicyBenefitsPeriodExpense

-25033000

usd

CY2021

us-gaap

Liability For Future Policy Benefits Period Expense

LiabilityForFuturePolicyBenefitsPeriodExpense

-55325000

usd

CY2023

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

6098484000

usd

CY2022

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

4553505000

usd

CY2021

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

2383196000

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

-235615000

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

-589867000

usd

CY2021

us-gaap

Operating Income Loss

OperatingIncomeLoss

-544481000

usd

CY2023

us-gaap

Interest Expense

InterestExpense

24603000

usd

CY2022

us-gaap

Interest Expense

InterestExpense

22623000

usd

CY2021

us-gaap

Interest Expense

InterestExpense

4720000

usd

CY2023

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-7082000

usd

CY2022

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

2415000

usd

CY2021

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-1201000

usd

CY2023

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

usd

CY2022

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

usd

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-20178000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-267300000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-610075000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-570580000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

3294000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-523000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

846000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

-270594000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

-609552000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

-571426000

usd

CY2023

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

134000

usd

CY2022

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

-3277000

usd

CY2021

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

1180000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-270728000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

-606275000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

-572606000

usd

CY2023

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-1.22

CY2023

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-1.22

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-2.85

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-2.85

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-3.20

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-3.20

CY2023

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

221655493

shares

CY2023

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

221655493

shares

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

212474615

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

212474615

shares

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

178967056

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

178967056

shares

CY2023

us-gaap

Profit Loss

ProfitLoss

-270594000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

-609552000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

-571426000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

11024000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

-6044000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

-4550000

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

-259570000

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

-615596000

usd

CY2021

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

-575976000

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

134000

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

-3277000

usd

CY2021

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

1180000

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-259704000

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-612319000

usd

CY2021

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-577156000

usd

CY2020Q4

us-gaap

Temporary Equity Shares Outstanding

TemporaryEquitySharesOutstanding

400904302

shares

CY2020Q4

us-gaap

Temporary Equity Carrying Amount Attributable To Parent

TemporaryEquityCarryingAmountAttributableToParent

1744911000

usd

CY2020Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

-1295893000

usd

CY2021

oscr

Temporary Equity Conversion To Permanent Equity Shares

TemporaryEquityConversionToPermanentEquityShares

400904302

shares

CY2021

oscr

Temporary Equity Conversion To Permanent Equity Value

TemporaryEquityConversionToPermanentEquityValue

1744911000

usd

CY2021

us-gaap

Stock Issued During Period Value Conversion Of Convertible Securities

StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

1744910000

usd

CY2021

us-gaap

Stock Issued During Period Value New Issues

StockIssuedDuringPeriodValueNewIssues

1338875000

usd

CY2021

oscr

Stock Issued During Period Value Warrants And Call Options Exercised

StockIssuedDuringPeriodValueWarrantsAndCallOptionsExercised

37071000

usd

CY2021

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

50009000

usd

CY2021

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

86296000

usd

CY2021

us-gaap

Noncontrolling Interest Increase From Subsidiary Equity Issuance

NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance

7230000

usd

CY2021

us-gaap

Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

-4550000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

-571426000

usd

CY2022Q4

us-gaap

Temporary Equity Shares Outstanding

TemporaryEquitySharesOutstanding

0

shares

CY2022Q4

us-gaap

Temporary Equity Carrying Amount Attributable To Parent

TemporaryEquityCarryingAmountAttributableToParent

0

usd

CY2021Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

1392522000

usd

CY2022

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

1299000

usd

CY2022

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

112329000

usd

CY2022

oscr

Adjustments To Additional Paid In Capital Joint Venture Contribution

AdjustmentsToAdditionalPaidInCapitalJointVentureContribution

1846000

usd

CY2022

us-gaap

Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

-6044000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

-609552000

usd

CY2022Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

892400000

usd

CY2023

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

3956000

usd

CY2023

us-gaap

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

166841000

usd

CY2023

oscr

Adjustments To Additional Paid In Capital Joint Venture Contribution

AdjustmentsToAdditionalPaidInCapitalJointVentureContribution

2490000

usd

CY2023

us-gaap

Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

11024000

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

-270594000

usd

CY2023Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

806117000

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

-609552000

usd

CY2021

us-gaap

Profit Loss

ProfitLoss

-571426000

usd

CY2023

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

58000

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-165000

usd

CY2021

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-101000

usd

CY2023

us-gaap

Gain Loss On Sale Of Investments

GainLossOnSaleOfInvestments

-70000

usd

CY2022

us-gaap

Gain Loss On Sale Of Investments

GainLossOnSaleOfInvestments

-1274000

usd

CY2021

us-gaap

Gain Loss On Sale Of Investments

GainLossOnSaleOfInvestments

209000

usd

CY2023

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

0

usd

CY2022

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

0

usd

CY2021

us-gaap

Fair Value Adjustment Of Warrants

FairValueAdjustmentOfWarrants

12856000

usd

CY2023

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

30694000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

15283000

usd

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

14605000

usd

CY2023

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

778000

usd

CY2022

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

713000

usd

CY2021

us-gaap

Amortization Of Financing Costs

AmortizationOfFinancingCosts

329000

usd

CY2023

us-gaap

Share Based Compensation

ShareBasedCompensation

159683000

usd

CY2022

us-gaap

Share Based Compensation

ShareBasedCompensation

112329000

usd

CY2021

us-gaap

Share Based Compensation

ShareBasedCompensation

86296000

usd

CY2023

us-gaap

Accretion Amortization Of Discounts And Premiums Investments

AccretionAmortizationOfDiscountsAndPremiumsInvestments

29374000

usd

CY2022

us-gaap

Accretion Amortization Of Discounts And Premiums Investments

AccretionAmortizationOfDiscountsAndPremiumsInvestments

-2480000

usd

CY2021

us-gaap

Accretion Amortization Of Discounts And Premiums Investments

AccretionAmortizationOfDiscountsAndPremiumsInvestments

-8031000

usd

CY2023

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

usd

CY2022

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

0

usd

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-20178000

usd

CY2023

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

28612000

usd

CY2022

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

2988000

usd

CY2021

us-gaap

Provision For Other Credit Losses

ProvisionForOtherCreditLosses

0

usd

CY2023

us-gaap

Increase Decrease In Premiums Receivable

IncreaseDecreaseInPremiumsReceivable

13405000

usd

CY2022

us-gaap

Increase Decrease In Premiums Receivable

IncreaseDecreaseInPremiumsReceivable

81049000

usd

CY2021

us-gaap

Increase Decrease In Premiums Receivable

IncreaseDecreaseInPremiumsReceivable

66953000

usd

CY2023

oscr

Increase Decrease In Risk Adjustment Transfer Receivables

IncreaseDecreaseInRiskAdjustmentTransferReceivables

2063000

usd

CY2022

oscr

Increase Decrease In Risk Adjustment Transfer Receivables

IncreaseDecreaseInRiskAdjustmentTransferReceivables

9202000

usd

CY2021

oscr

Increase Decrease In Risk Adjustment Transfer Receivables

IncreaseDecreaseInRiskAdjustmentTransferReceivables

9502000

usd

CY2023

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

-651693000

usd

CY2022

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

460897000

usd

CY2021

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

-147403000

usd

CY2023

us-gaap

Increase Decrease In Other Operating Assets

IncreaseDecreaseInOtherOperatingAssets

-11307000

usd

CY2022

us-gaap

Increase Decrease In Other Operating Assets

IncreaseDecreaseInOtherOperatingAssets

243000

usd

CY2021

us-gaap

Increase Decrease In Other Operating Assets

IncreaseDecreaseInOtherOperatingAssets

11299000

usd

CY2023

us-gaap

Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve

IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve

28258000

usd

CY2022

us-gaap

Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve

IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve

424146000

usd

CY2021

us-gaap

Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve

IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve

201667000

usd

CY2023

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

-13080000

usd

CY2022

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

3953000

usd

CY2021

us-gaap

Increase Decrease In Unearned Premiums

IncreaseDecreaseInUnearnedPremiums

3140000

usd

CY2023

us-gaap

Increase Decrease In Future Policy Benefit Reserves

IncreaseDecreaseInFuturePolicyBenefitReserves

1562000

usd

CY2022

us-gaap

Increase Decrease In Future Policy Benefit Reserves

IncreaseDecreaseInFuturePolicyBenefitReserves

-25033000

usd

CY2021

us-gaap

Increase Decrease In Future Policy Benefit Reserves

IncreaseDecreaseInFuturePolicyBenefitReserves

-55325000

usd

CY2023

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

-29180000

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

57811000

usd

CY2021

us-gaap

Increase Decrease In Accounts Payable And Accrued Liabilities

IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

98619000

usd

CY2023

us-gaap

Increase Decrease In Reinsurance Payables

IncreaseDecreaseInReinsurancePayables

-366626000

usd

CY2022

us-gaap

Increase Decrease In Reinsurance Payables

IncreaseDecreaseInReinsurancePayables

222418000

usd

CY2021

us-gaap

Increase Decrease In Reinsurance Payables

IncreaseDecreaseInReinsurancePayables

-138082000

usd

CY2023

oscr

Increase Decrease In Risk Adjustment Transfer Payable

IncreaseDecreaseInRiskAdjustmentTransferPayable

-460552000

usd

CY2022

oscr

Increase Decrease In Risk Adjustment Transfer Payable

IncreaseDecreaseInRiskAdjustmentTransferPayable

723095000

usd

CY2021

oscr

Increase Decrease In Risk Adjustment Transfer Payable

IncreaseDecreaseInRiskAdjustmentTransferPayable

78028000

usd

CY2023

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-272159000

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

380349000

usd

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-181745000

usd

CY2023

us-gaap

Payments To Acquire Available For Sale Securities Debt

PaymentsToAcquireAvailableForSaleSecuritiesDebt

836982000

usd

CY2022

us-gaap

Payments To Acquire Available For Sale Securities Debt

PaymentsToAcquireAvailableForSaleSecuritiesDebt

1192706000

usd

CY2021

us-gaap

Payments To Acquire Available For Sale Securities Debt

PaymentsToAcquireAvailableForSaleSecuritiesDebt

1810076000

usd

CY2023

us-gaap

Proceeds From Sale Of Available For Sale Securities Debt

ProceedsFromSaleOfAvailableForSaleSecuritiesDebt

31857000

usd

CY2022

us-gaap

Proceeds From Sale Of Available For Sale Securities Debt

ProceedsFromSaleOfAvailableForSaleSecuritiesDebt

360616000

usd

CY2021

us-gaap

Proceeds From Sale Of Available For Sale Securities Debt

ProceedsFromSaleOfAvailableForSaleSecuritiesDebt

624077000

usd

CY2023

us-gaap

Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities

1410166000

usd

CY2022

us-gaap

Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities

633467000

usd

CY2021

us-gaap

Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities

430694000

usd

CY2023

us-gaap

Payments To Acquire Productive Assets

PaymentsToAcquireProductiveAssets

25577000

usd

CY2022

us-gaap

Payments To Acquire Productive Assets

PaymentsToAcquireProductiveAssets

29012000

usd

CY2021

us-gaap

Payments To Acquire Productive Assets

PaymentsToAcquireProductiveAssets

25885000

usd

CY2023

us-gaap

Increase Decrease Of Restricted Investments

IncreaseDecreaseOfRestrictedInvestments

2277000

usd

CY2022

us-gaap

Increase Decrease Of Restricted Investments

IncreaseDecreaseOfRestrictedInvestments

-1116000

usd

CY2021

us-gaap

Increase Decrease Of Restricted Investments

IncreaseDecreaseOfRestrictedInvestments

-6675000

usd

CY2023

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

577187000

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-226519000

usd

CY2021

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-774515000

usd

CY2023

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

0

usd

CY2022

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

305000000

usd

CY2021

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

0

usd

CY2023

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

0

usd

CY2022

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

7035000

usd

CY2021

us-gaap

Payments Of Debt Issuance Costs

PaymentsOfDebtIssuanceCosts

0

usd

CY2023

us-gaap

Proceeds From Contributions From Affiliates

ProceedsFromContributionsFromAffiliates

2490000

usd

CY2022

us-gaap

Proceeds From Contributions From Affiliates

ProceedsFromContributionsFromAffiliates

1846000

usd

CY2021

us-gaap

Proceeds From Contributions From Affiliates

ProceedsFromContributionsFromAffiliates

0

usd

CY2023

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

0

usd

CY2022

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

0

usd

CY2021

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

153173000

usd

CY2023

us-gaap

Payments Of Debt Extinguishment Costs

PaymentsOfDebtExtinguishmentCosts

0

usd

CY2022

us-gaap

Payments Of Debt Extinguishment Costs

PaymentsOfDebtExtinguishmentCosts

0

usd

CY2021

us-gaap

Payments Of Debt Extinguishment Costs

PaymentsOfDebtExtinguishmentCosts

12994000

usd

CY2023

us-gaap

Proceeds From Issuance Initial Public Offering

ProceedsFromIssuanceInitialPublicOffering

0

usd

CY2022

us-gaap

Proceeds From Issuance Initial Public Offering

ProceedsFromIssuanceInitialPublicOffering

0

usd

CY2021

us-gaap

Proceeds From Issuance Initial Public Offering

ProceedsFromIssuanceInitialPublicOffering

1348321000

usd

CY2023

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

0

usd

CY2022

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

0

usd

CY2021

us-gaap

Payments Of Stock Issuance Costs

PaymentsOfStockIssuanceCosts

9447000

usd

CY2023

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

0

usd

CY2022

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

0

usd

CY2021

us-gaap

Proceeds From Warrant Exercises

ProceedsFromWarrantExercises

9191000

usd

CY2023

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

0

usd

CY2023

us-gaap

Prior Period Reclassification Adjustment Description

PriorPeriodReclassificationAdjustmentDescription

<div>Reclassification</div><div> </div><div>The Company has made certain reclassifications to prior period amounts to conform to the current period presentation within the accompanying Consolidated Financial Statements and notes to the Consolidated Financial Statements.</div>

CY2022

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

0

usd

CY2021

us-gaap

Proceeds From Minority Shareholders

ProceedsFromMinorityShareholders

7230000

usd

CY2023

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

3956000

usd

CY2022

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

1299000

usd

CY2021

us-gaap

Proceeds From Stock Options Exercised

ProceedsFromStockOptionsExercised

49584000

usd

CY2023

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

6446000

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

301110000

usd

CY2021

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

1238712000

usd

CY2023

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

311474000

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

454940000

usd

CY2021

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

282452000

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1580497000

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1125557000

usd

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

843105000

usd

CY2023Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1891971000

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1580497000

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1125557000

usd

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

1870315000

usd

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

1558595000

usd

CY2021Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

1103995000

usd

CY2023Q4

us-gaap

Restricted Cash And Cash Equivalents

RestrictedCashAndCashEquivalents

21656000

usd

CY2022Q4

us-gaap

Restricted Cash And Cash Equivalents

RestrictedCashAndCashEquivalents

21902000

usd

CY2021Q4

us-gaap

Restricted Cash And Cash Equivalents

RestrictedCashAndCashEquivalents

21562000

usd

CY2023Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1891971000

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1580497000

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

1125557000

usd

CY2023

us-gaap

Interest Paid Net

InterestPaidNet

23156000

usd

CY2022

us-gaap

Interest Paid Net

InterestPaidNet

10079000

usd

CY2021

us-gaap

Interest Paid Net

InterestPaidNet

4256000

usd

CY2023

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

2414000

usd

CY2022

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

1893000

usd

CY2021

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

697000

usd

CY2023

us-gaap

Conversion Of Stock Amount Issued1

ConversionOfStockAmountIssued1

0

usd

CY2022

us-gaap

Conversion Of Stock Amount Issued1

ConversionOfStockAmountIssued1

0

usd

CY2021

us-gaap

Conversion Of Stock Amount Issued1

ConversionOfStockAmountIssued1

1744911000

usd

CY2023

oscr

Net Exercise Of Preferred Stock Warrants To Common Stock

NetExerciseOfPreferredStockWarrantsToCommonStock

0

usd

CY2022

oscr

Net Exercise Of Preferred Stock Warrants To Common Stock

NetExerciseOfPreferredStockWarrantsToCommonStock

0

usd

CY2021

oscr

Net Exercise Of Preferred Stock Warrants To Common Stock

NetExerciseOfPreferredStockWarrantsToCommonStock

28248000

usd

CY2023

oscr

Fair Value Adjustment Preferred Stock Warrant Liability

FairValueAdjustmentPreferredStockWarrantLiability

0

usd

CY2022

oscr

Fair Value Adjustment Preferred Stock Warrant Liability

FairValueAdjustmentPreferredStockWarrantLiability

0

usd

CY2021

oscr

Fair Value Adjustment Preferred Stock Warrant Liability

FairValueAdjustmentPreferredStockWarrantLiability

13243000

usd

CY2023

us-gaap

Number Of Operating Segments

NumberOfOperatingSegments

1

segment

CY2023

us-gaap

Direct Premiums Earned

DirectPremiumsEarned

6418872000

usd

CY2023

us-gaap

Use Of Estimates

UseOfEstimates

<div style="text-align:justify">Use of Estimates</div><div style="text-align:justify"> </div><div style="text-align:justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Significant estimates inherent in the preparation of the accompanying audited Consolidated Financial Statements include healthcare costs incurred but not yet reported (“IBNR”), and risk adjustment. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ materially from these estimates.</div>

CY2023

us-gaap

Comparability Of Prior Year Financial Data

ComparabilityOfPriorYearFinancialData

<div style="text-align:justify">Change in Accounting Principle</div><div style="text-align:justify">For the year ended December 31, 2022, the Company elected to include anticipated net investment income in its determination of premium deficiency reserves. The accounting policy election to include net investment income is preferable because it best reflects the ultimate profitability of insurance contracts using all cash flows, inclusive of related investment income, and provides improved comparability with industry peers. This change is considered a change in accounting principle that requires retrospective application to all financial statement periods presented. However, because net investment income has historically been immaterial to the financial statements and to the premium deficiency reserve calculation, the effect of this change in accounting principle is immaterial to prior and current period balances. As a result, this change in accounting principle is being applied prospectively as of December 31, 2022.</div>

CY2022Q4

oscr

Premiums And Other Receivables Allowance For Credit Loss

PremiumsAndOtherReceivablesAllowanceForCreditLoss

2988000

usd

CY2021Q4

oscr

Premiums And Other Receivables Allowance For Credit Loss

PremiumsAndOtherReceivablesAllowanceForCreditLoss

0

usd

CY2023

oscr

Premiums And Other Receivables Allowance For Credit Loss Period Increase Decrease

PremiumsAndOtherReceivablesAllowanceForCreditLossPeriodIncreaseDecrease

28612000

usd

CY2022

oscr

Premiums And Other Receivables Allowance For Credit Loss Period Increase Decrease

PremiumsAndOtherReceivablesAllowanceForCreditLossPeriodIncreaseDecrease

2988000

usd

CY2023Q4

oscr

Premiums And Other Receivables Allowance For Credit Loss

PremiumsAndOtherReceivablesAllowanceForCreditLoss

31600000

usd

CY2022Q4

oscr

Premiums And Other Receivables Allowance For Credit Loss

PremiumsAndOtherReceivablesAllowanceForCreditLoss

2988000

usd

CY2023Q4

us-gaap

Liability For Title Claims And Claims Adjustment Expense

LiabilityForTitleClaimsAndClaimsAdjustmentExpense

241100000

usd

CY2022Q4

us-gaap

Liability For Title Claims And Claims Adjustment Expense

LiabilityForTitleClaimsAndClaimsAdjustmentExpense

251100000

usd

CY2022

us-gaap

Direct Premiums Earned

DirectPremiumsEarned

6704330000

usd

CY2021

us-gaap

Direct Premiums Earned

DirectPremiumsEarned

3420328000

usd

CY2023

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

228786000

usd

CY2022

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

138109000

usd

CY2021

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

16298000

usd

CY2023

oscr

Direct And Assumed Premiums Earned

DirectAndAssumedPremiumsEarned

6647658000

usd

CY2022

oscr

Direct And Assumed Premiums Earned

DirectAndAssumedPremiumsEarned

6842439000

usd

CY2021

oscr

Direct And Assumed Premiums Earned

DirectAndAssumedPremiumsEarned

3436626000

usd

CY2023

oscr

Premiums Earned Risk Adjustment

PremiumsEarnedRiskAdjustment

950680000

usd

CY2022

oscr

Premiums Earned Risk Adjustment

PremiumsEarnedRiskAdjustment

1507919000

usd

CY2021

oscr

Premiums Earned Risk Adjustment

PremiumsEarnedRiskAdjustment

723638000

usd

CY2023

oscr

Premiums Earned Before Premiums Ceded

PremiumsEarnedBeforePremiumsCeded

5696978000

usd

CY2022

oscr

Premiums Earned Before Premiums Ceded

PremiumsEarnedBeforePremiumsCeded

5334520000

usd

CY2021

oscr

Premiums Earned Before Premiums Ceded

PremiumsEarnedBeforePremiumsCeded

2712988000

usd

CY2023

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

10909000

usd

CY2022

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

1463403000

usd

CY2021

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

881968000

usd

CY2023

us-gaap

Premiums Earned Net

PremiumsEarnedNet

5686069000

usd

CY2022

us-gaap

Premiums Earned Net

PremiumsEarnedNet

3871117000

usd

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

1831020000

usd

CY2023Q4

us-gaap

Contract With Customer Receivable After Allowance For Credit Loss

ContractWithCustomerReceivableAfterAllowanceForCreditLoss

200000

usd

CY2022Q4

us-gaap

Contract With Customer Receivable After Allowance For Credit Loss

ContractWithCustomerReceivableAfterAllowanceForCreditLoss

33700000

usd

CY2023

oscr

Quota Share Reinsurance Program Percentage Of Premiums Ceded

QuotaShareReinsuranceProgramPercentageOfPremiumsCeded

0.45

CY2022

oscr

Quota Share Reinsurance Program Percentage Of Premiums Ceded

QuotaShareReinsuranceProgramPercentageOfPremiumsCeded

0.18

CY2021

oscr

Quota Share Reinsurance Program Percentage Of Premiums Ceded

QuotaShareReinsuranceProgramPercentageOfPremiumsCeded

0

CY2022

oscr

Quota Share Reinsurance Program Percentage Of Premiums Covered

QuotaShareReinsuranceProgramPercentageOfPremiumsCovered

0.29

CY2021

oscr

Quota Share Reinsurance Program Percentage Of Premiums Covered

QuotaShareReinsuranceProgramPercentageOfPremiumsCovered

0.34

CY2023Q4

oscr

Reinsurance Deposit Liability

ReinsuranceDepositLiability

7000000

usd

CY2022Q4

oscr

Reinsurance Deposit Liability

ReinsuranceDepositLiability

1800000

usd

CY2023

oscr

Ceded Premiums Earned Gross

CededPremiumsEarnedGross

-56000

usd

CY2022

oscr

Ceded Premiums Earned Gross

CededPremiumsEarnedGross

1524157000

usd

CY2021

oscr

Ceded Premiums Earned Gross

CededPremiumsEarnedGross

921953000

usd

CY2023

oscr

Ceded Premiums Experience Refund

CededPremiumsExperienceRefund

-10965000

usd

CY2022

oscr

Ceded Premiums Experience Refund

CededPremiumsExperienceRefund

60754000

usd

CY2021

oscr

Ceded Premiums Experience Refund

CededPremiumsExperienceRefund

39985000

usd

CY2023

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

10909000

usd

CY2022

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

1463403000

usd

CY2021

oscr

Ceded Premiums Earned Including Prior Period Adjustments

CededPremiumsEarnedIncludingPriorPeriodAdjustments

881968000

usd

CY2023

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

228786000

usd

CY2022

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

138109000

usd

CY2021

us-gaap

Assumed Premiums Earned

AssumedPremiumsEarned

16298000

usd

CY2023

oscr

Ceded Premiums Earned Net Of Assumed Premiums Earned

CededPremiumsEarnedNetOfAssumedPremiumsEarned

-217877000

usd

CY2022

oscr

Ceded Premiums Earned Net Of Assumed Premiums Earned

CededPremiumsEarnedNetOfAssumedPremiumsEarned

1325294000

usd

CY2021

oscr

Ceded Premiums Earned Net Of Assumed Premiums Earned

CededPremiumsEarnedNetOfAssumedPremiumsEarned

865670000

usd

CY2023

us-gaap

Policyholder Benefits And Claims Incurred Gross

PolicyholderBenefitsAndClaimsIncurredGross

4459702000

usd

CY2022

us-gaap

Policyholder Benefits And Claims Incurred Gross

PolicyholderBenefitsAndClaimsIncurredGross

4428000000

usd

CY2021

us-gaap

Policyholder Benefits And Claims Incurred Gross

PolicyholderBenefitsAndClaimsIncurredGross

2403108000

usd

CY2023

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

44736000

usd

CY2022

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

1290349000

usd

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

800769000

usd

CY2023

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

227058000

usd

CY2022

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

143147000

usd

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed

21656000

usd

CY2022Q4

us-gaap

Restricted Investments Noncurrent

RestrictedInvestmentsNoncurrent

5581000

usd

CY2023

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

4642024000

usd

CY2022

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

3280798000

usd

CY2021

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

1623995000

usd

CY2023

oscr

Other Insurance Expense Gross

OtherInsuranceExpenseGross

823455000

usd

CY2022

oscr

Other Insurance Expense Gross

OtherInsuranceExpenseGross

868385000

usd

CY2021

oscr

Other Insurance Expense Gross

OtherInsuranceExpenseGross

492609000

usd

CY2023

oscr

Ceded Commission Income

CededCommissionIncome

-1002000

usd

CY2022

oscr

Ceded Commission Income

CededCommissionIncome

161946000

usd

CY2021

oscr

Ceded Commission Income

CededCommissionIncome

82246000

usd

CY2023

oscr

Other Insurance Expense Net

OtherInsuranceExpenseNet

824457000

usd

CY2022

oscr

Other Insurance Expense Net

OtherInsuranceExpenseNet

706439000

usd

CY2021

oscr

Other Insurance Expense Net

OtherInsuranceExpenseNet

410363000

usd

CY2023Q4

oscr

Reinsurance Recoverable For Paid And Unpaid Ceded Claims And Claims Adjustments

ReinsuranceRecoverableForPaidAndUnpaidCededClaimsAndClaimsAdjustments

225705000

usd

CY2022Q4

oscr

Reinsurance Recoverable For Paid And Unpaid Ceded Claims And Claims Adjustments

ReinsuranceRecoverableForPaidAndUnpaidCededClaimsAndClaimsAdjustments

776266000

usd

CY2023Q4

oscr

Reinsurance Recoverable Ceded Commissions

ReinsuranceRecoverableCededCommissions

6185000

usd

CY2022Q4

oscr

Reinsurance Recoverable Ceded Commissions

ReinsuranceRecoverableCededCommissions

42805000

usd

CY2023Q4

oscr

Reinsurance Recoverable Experience Refunds

ReinsuranceRecoverableExperienceRefunds

9304000

usd

CY2022Q4

oscr

Reinsurance Recoverable Experience Refunds

ReinsuranceRecoverableExperienceRefunds

73816000

usd

CY2023Q4

us-gaap

Reinsurance Recoverables On Paid And Unpaid Losses

ReinsuranceRecoverablesOnPaidAndUnpaidLosses

241194000

usd

CY2022Q4

us-gaap

Reinsurance Recoverables On Paid And Unpaid Losses

ReinsuranceRecoverablesOnPaidAndUnpaidLosses

892887000

usd

CY2023Q4

us-gaap

Restricted Cash And Cash Equivalents Noncurrent

RestrictedCashAndCashEquivalentsNoncurrent

21656000

usd

CY2022Q4

us-gaap

Restricted Cash And Cash Equivalents Noncurrent

RestrictedCashAndCashEquivalentsNoncurrent

21902000

usd

CY2023Q4

us-gaap

Restricted Investments Noncurrent

RestrictedInvestmentsNoncurrent

8214000

usd

CY2023Q4

us-gaap

Restricted Cash And Investments Noncurrent

RestrictedCashAndInvestmentsNoncurrent

29870000

usd

CY2022Q4

us-gaap

Restricted Cash And Investments Noncurrent

RestrictedCashAndInvestmentsNoncurrent

27483000

usd

CY2023Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

1053859000

usd

CY2023Q4

us-gaap

Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax

AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

2543000

usd

CY2023Q4

us-gaap

Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax

AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

1260000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

1055142000

usd

CY2022Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

1629814000

usd

CY2022Q4

us-gaap

Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax

AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

155000

usd

CY2022Q4

us-gaap

Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax

AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

9763000

usd

CY2022Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

1620206000

usd

CY2023Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions

133

security

CY2023Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

559336000

usd

CY2023Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

1161000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions

308

security

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

724614000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

1775000

usd

CY2023Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions

23

security

CY2023Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

30096000

usd

CY2023Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

99000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions

291

security

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

516085000

usd

CY2022Q4

us-gaap

Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

7988000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

690694000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Maturities Within One Year Fair Value

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

689833000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

363165000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

365309000

usd

CY2023Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

1053859000

usd

CY2023Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

1055142000

usd

CY2023

us-gaap

Gross Investment Income Operating

GrossInvestmentIncomeOperating

156265000

usd

CY2022

us-gaap

Gross Investment Income Operating

GrossInvestmentIncomeOperating

28632000

usd

CY2021

us-gaap

Gross Investment Income Operating

GrossInvestmentIncomeOperating

3237000

usd

CY2023

us-gaap

Investment Income Investment Expense

InvestmentIncomeInvestmentExpense

818000

usd

CY2022

us-gaap

Investment Income Investment Expense

InvestmentIncomeInvestmentExpense

1038000

usd

CY2022Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

5100000

usd

CY2021

us-gaap

Investment Income Investment Expense

InvestmentIncomeInvestmentExpense

842000

usd

CY2023

us-gaap

Net Investment Income

NetInvestmentIncome

155447000

usd

CY2022

us-gaap

Net Investment Income

NetInvestmentIncome

27594000

usd

CY2021

us-gaap

Net Investment Income

NetInvestmentIncome

2395000

usd

CY2023Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

6600000

usd

CY2023

us-gaap

Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense

ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

<div style="text-align:justify">The following table provides a rollforward of the Company’s beginning and ending benefits payable and claims adjustment expenses ("CAE") payable balances for the years ended December 31, 2023, 2022 and 2021:</div><div style="padding-right:13.5pt"> </div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center">Year Ended December 31, 2023</div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(in thousands)</td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Benefits Payable</td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Unallocated Claims Adjustment Expense</td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits payable, beginning of the period</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">937,727 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">12,712 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">950,439 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Less: Reinsurance recoverable</td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">277,944 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">277,944 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits payable, beginning of the period, net</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">659,783 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">12,712 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">672,495 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Claims incurred and CAE</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Current year</td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">4,622,263 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">105,565 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">4,727,828 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">19,761 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">19,761 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Total claims incurred and CAE, net</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">4,642,024 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">105,565 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">4,747,589 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Claims paid and CAE</td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Current year</td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">3,840,009 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">94,807 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">3,934,816 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">552,923 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">10,278 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">563,201 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Total claims and CAE paid, net</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">4,392,932 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">105,085 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">4,498,017 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits and CAE payable, end of period, net</td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">908,875 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">13,192 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">922,067 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Add: Reinsurance recoverable</td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">57,111 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">57,111 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits and CAE payable, end of period</td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">965,986 </td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">13,192 </td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">979,178 </td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div> </div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center">Year Ended December 31, 2022</div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(in thousands)</td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Benefits Payable</td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Unallocated Claims Adjustment Expense</td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits payable, beginning of the period</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">513,582 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">9,101 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">522,683 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Less: Reinsurance recoverable</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">159,180 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">159,180 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits payable, beginning of the period, net</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">354,402 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">9,101 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">363,503 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Claims incurred and CAE</td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Current year</td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">3,279,460 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">117,541 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">3,397,001 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,338 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,338 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Total claims incurred and CAE, net</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">3,280,798 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">117,541 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">3,398,339 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Claims paid and CAE</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Current year</td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">2,726,912 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">106,871 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">2,833,783 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">248,505 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">7,059 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">255,564 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Total claims and CAE paid, net</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">2,975,417 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">113,930 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">3,089,347 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits and CAE payable, end of period, net</td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">659,783 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">12,712 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">672,495 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Add: Reinsurance recoverable</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">277,944 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">277,944 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits and CAE payable, end of period</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">937,727 </td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">12,712 </td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">950,439 </td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center">Year Ended December 31, 2021</div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(in thousands)</td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Benefits Payable</td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Unallocated Claims Adjustment Expense</td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits payable, beginning of the period</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">311,914 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,509 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">317,423 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Less: Reinsurance recoverable</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">132,658 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">132,658 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits payable, beginning of the period, net</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">179,256 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">5,509 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">184,765 </td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Claims incurred and CAE</td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Current year</td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">1,640,247 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">73,892 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">1,714,139 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(16,252)</td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(16,252)</td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Total claims incurred and CAE, net</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">1,623,995 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">73,892 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">1,697,887 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Claims paid and CAE</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Current year</td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">1,346,870 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">64,791 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">1,411,661 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">101,978 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">5,509 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">107,487 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Total claims and CAE paid, net</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">1,448,848 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">70,300 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">1,519,148 </td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits and CAE payable, end of period, net</td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">354,402 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">9,101 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom">363,503 </td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Add: Reinsurance recoverable</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">159,180 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">159,180 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom">Benefits and CAE payable, end of period</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">513,582 </td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">9,101 </td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">522,683 </td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>

CY2022Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

937727000

usd

CY2022Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

12712000

usd

CY2022Q4

oscr

Liability For Claims And Claims Adjustment Expense And Liability For Unpaid Claims And Claims Adjustment Expense Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments

950439000

usd

CY2022Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

277944000

usd

CY2022Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

277944000

usd

CY2022Q4

oscr

Liability For Claims And Claims Adjustment Expense Net Of Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

659783000

usd

CY2022Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

12712000

usd

CY2022Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

672495000

usd

CY2023

oscr

Liability For Unpaid Claims Incurred Claims Current Year

LiabilityForUnpaidClaimsIncurredClaimsCurrentYear

4622263000

usd

CY2023

oscr

Claims Adjustment Expense Incurred Claims Current Year

ClaimsAdjustmentExpenseIncurredClaimsCurrentYear

105565000

usd

CY2023

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

4727828000

usd

CY2023

oscr

Liability For Unpaid Claims Incurred Claims Prior Year

LiabilityForUnpaidClaimsIncurredClaimsPriorYear

19761000

usd

CY2023

oscr

Claims Adjustment Expense Incurred Claims Prior Year

ClaimsAdjustmentExpenseIncurredClaimsPriorYear

0

usd

CY2023

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

19761000

usd

CY2023

oscr

Liability For Unpaid Claims Incurred Claims

LiabilityForUnpaidClaimsIncurredClaims

4642024000

usd

CY2023

oscr

Claims Adjustment Expense Incurred Claims

ClaimsAdjustmentExpenseIncurredClaims

105565000

usd

CY2023

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1

4747589000

usd

CY2023

oscr

Liability For Unpaid Claims Claims Paid Current Year

LiabilityForUnpaidClaimsClaimsPaidCurrentYear

3840009000

usd

CY2023

oscr

Claims Adjustment Expense Claims Paid Current Year

ClaimsAdjustmentExpenseClaimsPaidCurrentYear

94807000

usd

CY2023

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

3934816000

usd

CY2023

oscr

Liability For Unpaid Claims Claims Paid Prior Year

LiabilityForUnpaidClaimsClaimsPaidPriorYear

552923000

usd

CY2023

oscr

Claims Adjustment Expense Claims Paid Prior Year

ClaimsAdjustmentExpenseClaimsPaidPriorYear

10278000

usd

CY2023

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

563201000

usd

CY2023

oscr

Liability For Unpaid Claims Claims Paid

LiabilityForUnpaidClaimsClaimsPaid

4392932000

usd

CY2023

oscr

Claims Adjustment Expense Claims Paid

ClaimsAdjustmentExpenseClaimsPaid

105085000

usd

CY2023

us-gaap

Payments For Losses And Loss Adjustment Expense

PaymentsForLossesAndLossAdjustmentExpense

4498017000

usd

CY2023Q4

oscr

Liability For Claims And Claims Adjustment Expense Net Of Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

908875000

usd

CY2023Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

13192000

usd

CY2023Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

922067000

usd

CY2023Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

57111000

usd

CY2023Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

965986000

usd

CY2023Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

13192000

usd

CY2023Q4

oscr

Liability For Claims And Claims Adjustment Expense And Liability For Unpaid Claims And Claims Adjustment Expense Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments

979178000

usd

CY2021Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

513582000

usd

CY2021Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

9101000

usd

CY2021Q4

oscr

Liability For Claims And Claims Adjustment Expense And Liability For Unpaid Claims And Claims Adjustment Expense Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments

522683000

usd

CY2021Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

159180000

usd

CY2021Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

159180000

usd

CY2021Q4

oscr

Liability For Claims And Claims Adjustment Expense Net Of Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

354402000

usd

CY2021Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

9101000

usd

CY2021Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

363503000

usd

CY2022

oscr

Liability For Unpaid Claims Incurred Claims Current Year

LiabilityForUnpaidClaimsIncurredClaimsCurrentYear

3279460000

usd

CY2022

oscr

Claims Adjustment Expense Incurred Claims Current Year

ClaimsAdjustmentExpenseIncurredClaimsCurrentYear

117541000

usd

CY2022

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

3397001000

usd

CY2022

oscr

Liability For Unpaid Claims Incurred Claims Prior Year

LiabilityForUnpaidClaimsIncurredClaimsPriorYear

1338000

usd

CY2022

oscr

Claims Adjustment Expense Incurred Claims Prior Year

ClaimsAdjustmentExpenseIncurredClaimsPriorYear

0

usd

CY2022

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

1338000

usd

CY2022

oscr

Liability For Unpaid Claims Incurred Claims

LiabilityForUnpaidClaimsIncurredClaims

3280798000

usd

CY2022

oscr

Claims Adjustment Expense Incurred Claims

ClaimsAdjustmentExpenseIncurredClaims

117541000

usd

CY2022

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1

3398339000

usd

CY2022

oscr

Liability For Unpaid Claims Claims Paid Current Year

LiabilityForUnpaidClaimsClaimsPaidCurrentYear

2726912000

usd

CY2022

oscr

Claims Adjustment Expense Claims Paid Current Year

ClaimsAdjustmentExpenseClaimsPaidCurrentYear

106871000

usd

CY2022

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

2833783000

usd

CY2022

oscr

Liability For Unpaid Claims Claims Paid Prior Year

LiabilityForUnpaidClaimsClaimsPaidPriorYear

248505000

usd

CY2022

oscr

Claims Adjustment Expense Claims Paid Prior Year

ClaimsAdjustmentExpenseClaimsPaidPriorYear

7059000

usd

CY2022

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

255564000

usd

CY2022

oscr

Liability For Unpaid Claims Claims Paid

LiabilityForUnpaidClaimsClaimsPaid

2975417000

usd

CY2022

oscr

Claims Adjustment Expense Claims Paid

ClaimsAdjustmentExpenseClaimsPaid

113930000

usd

CY2022

us-gaap

Payments For Losses And Loss Adjustment Expense

PaymentsForLossesAndLossAdjustmentExpense

3089347000

usd

CY2022Q4

oscr

Liability For Claims And Claims Adjustment Expense Net Of Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

659783000

usd

CY2022Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

12712000

usd

CY2022Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

672495000

usd

CY2022Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

277944000

usd

CY2022Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

277944000

usd

CY2022Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

937727000

usd

CY2022Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

12712000

usd

CY2022Q4

oscr

Liability For Claims And Claims Adjustment Expense And Liability For Unpaid Claims And Claims Adjustment Expense Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments

950439000

usd

CY2020Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

311914000

usd

CY2020Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

5509000

usd

CY2020Q4

oscr

Liability For Claims And Claims Adjustment Expense And Liability For Unpaid Claims And Claims Adjustment Expense Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments

317423000

usd

CY2020Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

132658000

usd

CY2020Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

132658000

usd

CY2020Q4

oscr

Liability For Claims And Claims Adjustment Expense Net Of Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

179256000

usd

CY2020Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

5509000

usd

CY2020Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

184765000

usd

CY2021

oscr

Liability For Unpaid Claims Incurred Claims Current Year

LiabilityForUnpaidClaimsIncurredClaimsCurrentYear

1640247000

usd

CY2021

oscr

Claims Adjustment Expense Incurred Claims Current Year

ClaimsAdjustmentExpenseIncurredClaimsCurrentYear

73892000

usd

CY2021

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

1714139000

usd

CY2021

oscr

Liability For Unpaid Claims Incurred Claims Prior Year

LiabilityForUnpaidClaimsIncurredClaimsPriorYear

-16252000

usd

CY2021

oscr

Claims Adjustment Expense Incurred Claims Prior Year

ClaimsAdjustmentExpenseIncurredClaimsPriorYear

0

usd

CY2021

us-gaap

Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense

SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

-16252000

usd

CY2021

oscr

Liability For Unpaid Claims Incurred Claims

LiabilityForUnpaidClaimsIncurredClaims

1623995000

usd

CY2021

oscr

Claims Adjustment Expense Incurred Claims

ClaimsAdjustmentExpenseIncurredClaims

73892000

usd

CY2021

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1

1697887000

usd

CY2021

oscr

Liability For Unpaid Claims Claims Paid Current Year

LiabilityForUnpaidClaimsClaimsPaidCurrentYear

1346870000

usd

CY2021

oscr

Claims Adjustment Expense Claims Paid Current Year

ClaimsAdjustmentExpenseClaimsPaidCurrentYear

64791000

usd

CY2021

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

1411661000

usd

CY2021

oscr

Liability For Unpaid Claims Claims Paid Prior Year

LiabilityForUnpaidClaimsClaimsPaidPriorYear

101978000

usd

CY2021

oscr

Claims Adjustment Expense Claims Paid Prior Year

ClaimsAdjustmentExpenseClaimsPaidPriorYear

5509000

usd

CY2021

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

107487000

usd

CY2021

oscr

Liability For Unpaid Claims Claims Paid

LiabilityForUnpaidClaimsClaimsPaid

1448848000

usd

CY2021

oscr

Claims Adjustment Expense Claims Paid

ClaimsAdjustmentExpenseClaimsPaid

70300000

usd

CY2021

us-gaap

Payments For Losses And Loss Adjustment Expense

PaymentsForLossesAndLossAdjustmentExpense

1519148000

usd

CY2021Q4

oscr

Liability For Claims And Claims Adjustment Expense Net Of Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseNetOfReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

354402000

usd

CY2021Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

9101000

usd

CY2021Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Net

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet

363503000

usd

CY2021Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

159180000

usd

CY2021Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

159180000

usd

CY2021Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

513582000

usd

CY2021Q4

us-gaap

Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments

LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments

9101000

usd

CY2021Q4

oscr

Liability For Claims And Claims Adjustment Expense And Liability For Unpaid Claims And Claims Adjustment Expense Adjustments

LiabilityForClaimsAndClaimsAdjustmentExpenseAndLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAdjustments

522683000

usd

CY2023Q4

us-gaap

Shortduration Insurance Contracts Incurred Claims And Allocated Claim Adjustment Expense Net

ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet

9568198000

usd

CY2023Q4

us-gaap

Shortduration Insurance Contracts Cumulative Paid Claims And Allocated Claim Adjustment Expense Net

ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet

8671250000

usd

CY2023Q4

us-gaap

Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net Not Separately Presented

ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented

11927000

usd

CY2023Q4

us-gaap

Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net

ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet

908875000

usd

CY2023Q4

us-gaap

Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net

ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet

908875000

usd

CY2022Q4

us-gaap

Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net

ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet

659783000

usd

CY2023Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

57111000

usd

CY2022Q4

us-gaap

Reinsurance Recoverable For Unpaid Claims And Claims Adjustments

ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments

277944000

usd

CY2023Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

965986000

usd

CY2022Q4

us-gaap

Liability For Claims And Claims Adjustment Expense

LiabilityForClaimsAndClaimsAdjustmentExpense

937727000

usd

CY2023

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

166841000

usd

CY2022

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

112329000

usd

CY2021

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

86296000

usd

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

28728889

shares

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

10.01

CY2022

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y9M21D

CY2022Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

2073000

usd

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

1665456

shares

CY2023

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

6.35

CY2023

us-gaap

Stock Issued During Period Shares Stock Options Exercised

StockIssuedDuringPeriodSharesStockOptionsExercised

1771493

shares

CY2023

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

2.23

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

8489000

usd

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

2244740

shares

CY2023

us-gaap

Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price

ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

11.39

CY2023Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

26378112

shares

CY2023Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

10.18

CY2023

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

P5Y4M6D

CY2023Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

15700000

usd

CY2023Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

23559805

shares

CY2023Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

10.12

CY2023

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

P4Y11M26D

CY2023Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1

SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

11409000

usd

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

3.74

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

8.69

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

8500000

usd

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

1000000

usd

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

111000000

usd

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross

ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

0

shares

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum

0.035

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum

0.047

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum

0.005

CY2021

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum

0.012

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum

0.582

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum

0.594

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum

0.392

CY2022

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum

ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum

0.445

CY2023Q4

us-gaap

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options

EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

12800000

usd

CY2023

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost

ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost

46300000

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

-270728000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

-606275000

usd

CY2021

us-gaap

Net Income Loss

NetIncomeLoss

-572606000

usd

CY2023

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

221655493

shares

CY2023

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

221655493

shares

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

212474615

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

212474615

shares

CY2021

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

178967056

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

178967056

shares

CY2023

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-1.22

CY2023

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-1.22

CY2022

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-2.85

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-2.85

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

-3.20

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-3.20

CY2023

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

94057744

shares

CY2022

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

91441827

shares

CY2021

us-gaap

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

50115261

shares

CY2023

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

3222000

usd

CY2022

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

-358000

usd

CY2021

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

947000

usd

CY2023

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

14000

usd

CY2022

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

0

usd

CY2021

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

0

usd

CY2023

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

3236000

usd

CY2022

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

-358000

usd

CY2021

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

947000

usd

CY2023

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

58000

usd

CY2022

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-165000

usd

CY2021

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-101000

usd

CY2023

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

0

usd

CY2022

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

0

usd

CY2021

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

0

usd

CY2023

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

58000

usd

CY2022

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-165000

usd

CY2021

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-101000

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

3294000

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

-523000

usd

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

846000

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-267300000

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-610075000

usd

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-570580000

usd

CY2023

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.2100

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.2100

CY2021

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.2100

CY2023

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

-0.0123

CY2022

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.0600

CY2021

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.0090

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.1108

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.2327

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance

EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

-0.2162

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost

-0.0165

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost

-0.0192

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost

0.0181

CY2023

oscr

Effective Income Tax Rate Reconciliation Nondeductible Expense Salary Percent

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSalaryPercent

-0.0836

CY2022

oscr

Effective Income Tax Rate Reconciliation Nondeductible Expense Salary Percent

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSalaryPercent

-0.0156

CY2021

oscr

Effective Income Tax Rate Reconciliation Nondeductible Expense Salary Percent

EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSalaryPercent

-0.0225

CY2023

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0.0009

CY2022

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

-0.0016

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Other Adjustments

EffectiveIncomeTaxRateReconciliationOtherAdjustments

0.0001

CY2023

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.0123

CY2022

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.0009

CY2021

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

-0.0015

CY2023Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

548147000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

529293000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves

1213000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves

798000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

2396000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

5284000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

17736000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

16021000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses

5786000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses

4991000

usd

CY2023Q4

oscr

Deferred Tax Assets Start Up Costs

DeferredTaxAssetsStartUpCosts

2805000

usd

CY2022Q4

oscr

Deferred Tax Assets Start Up Costs

DeferredTaxAssetsStartUpCosts

3252000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve

2756000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve

3311000

usd

CY2023Q4

us-gaap

Deferred Tax Asset Interest Carryforward

DeferredTaxAssetInterestCarryforward

0

usd

CY2022Q4

us-gaap

Deferred Tax Asset Interest Carryforward

DeferredTaxAssetInterestCarryforward

1242000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Property Plant And Equipment

DeferredTaxAssetsPropertyPlantAndEquipment

6600000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Property Plant And Equipment

DeferredTaxAssetsPropertyPlantAndEquipment

1483000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Investments

DeferredTaxAssetsInvestments

21000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Investments

DeferredTaxAssetsInvestments

2040000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

13204000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

1972000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

600664000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

569687000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

591701000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

564392000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

8963000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

5295000

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities Prepaid Expenses

DeferredTaxLiabilitiesPrepaidExpenses

2830000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Prepaid Expenses

DeferredTaxLiabilitiesPrepaidExpenses

3485000

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

5429000

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

1038000

usd

CY2023Q4

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

8259000

usd

CY2022Q4

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

4523000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

704000

usd

CY2022Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

772000

usd

CY2023Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

591700000

usd

CY2021Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

usd

CY2023Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

usd

CY2022Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

0

usd

CY2022

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Expense

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense

0

usd

CY2023

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Expense

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense

0

usd

CY2021

us-gaap

Unrecognized Tax Benefits Income Tax Penalties And Interest Expense

UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense

0

usd

CY2023Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

62873000

usd

CY2022Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

68001000

usd

CY2023Q4

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

14175000

usd

CY2022Q4

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

12824000

usd

CY2023Q4

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

66803000

usd

CY2022Q4

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

72175000

usd

CY2023

us-gaap

Lease Cost

LeaseCost

14700000

usd

CY2022

us-gaap

Lease Cost

LeaseCost

14800000

usd

CY2021

us-gaap

Lease Cost

LeaseCost

15200000

usd

CY2023

us-gaap

Operating Lease Payments

OperatingLeasePayments

14000000

usd

CY2022

us-gaap

Operating Lease Payments

OperatingLeasePayments

14800000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due Next Twelve Months

LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

14175000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Two

LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

14360000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Three

LesseeOperatingLeaseLiabilityPaymentsDueYearThree

16445000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Four

LesseeOperatingLeaseLiabilityPaymentsDueYearFour

17099000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due Year Five

LesseeOperatingLeaseLiabilityPaymentsDueYearFive

17168000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due After Year Five

LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

38119000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Payments Due

LesseeOperatingLeaseLiabilityPaymentsDue

117366000

usd

CY2023Q4

us-gaap

Lessee Operating Lease Liability Undiscounted Excess Amount

LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

36388000

usd

CY2023Q4

us-gaap

Operating Lease Liability

OperatingLeaseLiability

80978000

usd

CY2023Q4

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P7Y2M12D

CY2023Q4

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.1064

CY2023Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

150007000

usd

CY2022Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

117272000

usd

CY2023Q4

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

88077000

usd

CY2022Q4

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

57384000

usd

CY2023Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

61930000

usd

CY2022Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

59888000

usd

CY2023

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

30700000

usd

CY2022

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

15300000

usd

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

14600000

usd

CY2021Q1

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

82500000

shares

CY2023Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Balance

StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

800600000

usd

CY2022Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Balance

StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

701500000

usd

CY2022Q4

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

314600

shares

CY2023Q4

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

314600

shares

CY2023Q4

ecd

Non Rule10b51 Arr Adopted Flag

NonRule10b51ArrAdoptedFlag

false

CY2023Q4

ecd

Rule10b51 Arr Adopted Flag

Rule10b51ArrAdoptedFlag

false

CY2023Q4

ecd

Non Rule10b51 Arr Trmntd Flag

NonRule10b51ArrTrmntdFlag

false

CY2023Q4

ecd

Rule10b51 Arr Trmntd Flag

Rule10b51ArrTrmntdFlag

false

Name	View Source	Status
0001568651-24-000006-index-headers.html	Edgar Link	pending
0001568651-24-000006-index.html	Edgar Link	pending
0001568651-24-000006.txt	Edgar Link	pending
0001568651-24-000006-xbrl.zip	Edgar Link	pending
a202310-koscrex311.htm	Edgar Link	pending
a202310-koscrex312.htm	Edgar Link	pending
a202310-koscrex321.htm	Edgar Link	pending
a202310-koscrex322.htm	Edgar Link	pending
ex1024amendednon-employeed.htm	Edgar Link	pending
ex1052024formofrestricteds.htm	Edgar Link	pending
ex1062024formofrestricteds.htm	Edgar Link	pending
ex231edgarconsentformxfina.htm	Edgar Link	pending
ex971oscarhealthincpolicyf.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oscr-20231231.htm	Edgar Link	pending
oscr-20231231.xsd	Edgar Link	pending
oscr-20231231_g1.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
oscr-20231231_cal.xml	Edgar Link	unprocessable
oscr-20231231_def.xml	Edgar Link	unprocessable
oscr-20231231_lab.xml	Edgar Link	unprocessable
oscr-20231231_pre.xml	Edgar Link	unprocessable
oscr-20231231_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OSCR
Oscar Health, Inc. Stock $oscr

2023 Q4 Form 10-K Financial Statement

#000156865124000006 Filed on February 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OSCR Oscar Health, Inc. Stock $oscr

2023 Q4 Form 10-K Financial Statement

#000156865124000006 Filed on February 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OSCR
Oscar Health, Inc. Stock $oscr